510(k) Report

510(k) · Cleared

Cleared

Modification to Dimension NT-Probnp Flex Reagent Cartridge Method

K042347510(k) TraditionalCleared Nov 19, 200481-day reviewClass II21 CFR 862.1117

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dade Behring, Inc. · NBC Test, Natriuretic Peptide

Cleared on Nov 19, 2004 as substantially equivalent to K032646 (Roche Diagnostics Corp., 2003) and 1 other predicate after an 81-day review. Its family tree reaches back 3 generations to 2000. 1 later device descends from it.

Decided
Nov 19, 2004
Review
81 days
Class
Class II
Product code
NBC
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to DEN000010 (2000). 1 later device descends from it, 1 citing it directly.

  1. Root · 3 generations backDEN000010 Triage B-Type Natriuretic Peptide (BNP) TestBiosite Incorporated · 2000
  2. 2 generations backK022516 Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 2002
  3. 1 generation backK032646 Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 2003
  4. This deviceK042347 Modification to Dimension NT-Probnp Flex Reagent Cartridge MethodDade Behring, Inc. · 2004
  5. Descendant · cites it directly · 0 of its ownK071767 Dimensions PBNP Flex Reagent Cartridge, Model RF423ADade Behring, Inc. · 2007

Most influential descendants

Showing 1 of 1 · See all
  • K071767Dimensions PBNP Flex Reagent Cartridge, Model RF423ADade Behring, Inc. · 2007 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3DEN000010Triage B-Type Natriuretic Peptide (BNP) TestBiosite Incorporated2000—
−2K022516Elecsys Probnp ImmunoassayRoche Diagnostics Corp.2002—
−1K032646Elecsys Probnp ImmunoassayRoche Diagnostics Corp.2003—
0 (this device)K042347Modification to Dimension NT-Probnp Flex Reagent Cartridge MethodDade Behring, Inc.2004—
+1K071767Dimensions PBNP Flex Reagent Cartridge, Model RF423ADade Behring, Inc.2007—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
FIG. 1 — Lineage of K042347, 2000–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBC device

  1. #1 K262109 Access NT-proBNPscore 13.8 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K032646Elecsys Probnp Immunoassay
Summary page 1
…FDA Reviewers" - 11/30/2000 Predicate Device(s): Roche Diagnostics Elecsys® proBNP immunoassay (K(02251 6/K032646) Device Description(s): Method The Dade Behring Dimension® NT-proBNP (PBNP) Flex® reagent cartridge method is an in vitro diagn…
Roche Diagnostics Corp.2003—
*K022516Elecsys Probnp Immunoassay
Summary page 2
…Dimension® PBNP Roche Elecsys® proBNP (K041417) (K032646/K022516) For the in vitro quantitative For the in vitro quantitative det…
Roche Diagnostics Corp.2002—

Also cleared against K032646: 7 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K071767Dimensions PBNP Flex Reagent Cartridge, Model RF423ADade Behring, Inc.20070

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 4 years and passes through 3 companies; a new generation was cleared every 1.0 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K071767 (Dade Behring, Inc., 2007) has gone furthest, with 0 descendants of its own.
  • 7 other devices also cite its predicate K032646.

How does its category compare?

All NBC devices

NBC Test, Natriuretic Peptide: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NBC

1in 2025

2007: 22008: 72010: 12020: 12021: 22022: 12023: 22024: 12025: 12026 (partial year): 4
2007high 7 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBC

126in 2008

2008: 126 days median2026 (partial year): 94 days median
2007high 126 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBC

1in 2020

2010: 12012: 22014: 12015: 12018: 12020: 1
2007high 2 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NBC

17in 2025

2007: 172008: 152009: 352010: 612011: 532012: 232013: 132014: 702015: 432016: 312017: 92018: 72019: 92020: 62022: 42023: 262024: 142025: 17
2007high 70 (2014) · low 0 (2021)2025

MAUDE reports naming product code NBC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—017
20087126015
20090—035
20101—161
20110—053
20120—223
20130—013
20140—170
20150—143
20160—031
20170—09
20180—17
20190—09
20201—16
20212—00
20221—04
20232—026
20241—014
20251—017
20264940—

What is it indicated for?

The Dimension® PBNP Flex® method is an in vitro diagnostic assay for the quantitative determination of N-terminal pro-brain natriuretic peptide (NT-proBNP) in human plasma. Measurements of NT-proBNP are used as an aid in the diagnosis of individuals suspected of having congestive heart failure and for risk stratification and severity assessment of patients with acute coronary syndrome and heart failure.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K042347: Modification to Dimension NT-Probnp Flex Reagent Cartridge Method.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K042347

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026